Non-steroidal mineralocorticoid receptor antagonism for the treatment of cardiovascular and renal disease
出版年份 2015 全文链接
标题
Non-steroidal mineralocorticoid receptor antagonism for the treatment of cardiovascular and renal disease
作者
关键词
-
出版物
EUROPEAN JOURNAL OF HEART FAILURE
Volume 18, Issue 1, Pages 28-37
出版商
Wiley
发表日期
2015-12-04
DOI
10.1002/ejhf.444
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Rationale and design of MinerAlocorticoid Receptor antagonist Tolerability Study-Heart Failure (ARTS-HF): a randomized study of finerenone vs. eplerenone in patients who have worsening chronic heart failure with diabetes and/or chronic kidney disease
- (2015) Bertram Pitt et al. EUROPEAN JOURNAL OF HEART FAILURE
- Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy
- (2015) George L. Bakris et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Rationale, Design, and Baseline Characteristics of ARTS-DN: A Randomized Study to Assess the Safety and Efficacy of Finerenone in Patients with Type 2 Diabetes Mellitus and a Clinical Diagnosis of Diabetic Nephropathy
- (2015) Luis M. Ruilope et al. AMERICAN JOURNAL OF NEPHROLOGY
- Updated National and International Hypertension Guidelines: A Review of Current Recommendations
- (2014) Sverre Kjeldsen et al. DRUGS
- Serum Aldosterone and Death, End-Stage Renal Disease, and Cardiovascular Events in Blacks and Whites
- (2014) Rajat Deo et al. HYPERTENSION
- Finerenone, a Novel Selective Nonsteroidal Mineralocorticoid Receptor Antagonist Protects From Rat Cardiorenal Injury
- (2014) Peter Kolkhof et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Comparison of Agents That Affect Aldosterone Action
- (2014) Juan Tamargo et al. SEMINARS IN NEPHROLOGY
- Effects of Mineralocorticoid Receptor Antagonists on the Risk of Sudden Cardiac Death in Patients With Left Ventricular Systolic Dysfunction
- (2013) Srinivas R. Bapoje et al. Circulation-Heart Failure
- Incidence, Determinants, and Prognostic Significance of Hyperkalemia and Worsening Renal Function in Patients With Heart Failure Receiving the Mineralocorticoid Receptor Antagonist Eplerenone or Placebo in Addition to Optimal Medical Therapy
- (2013) Patrick Rossignol et al. Circulation-Heart Failure
- The ARTS of third-generation mineralocorticoid receptor antagonists: achieving cardiovascular benefit with minimized renal side effects?
- (2013) Johann Bauersachs EUROPEAN HEART JOURNAL
- Safety and tolerability of the novel non-steroidal mineralocorticoid receptor antagonist BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease: a randomized, double-blind trial
- (2013) Bertram Pitt et al. EUROPEAN HEART JOURNAL
- Co-morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot Survey
- (2013) Vincent M. van Deursen et al. EUROPEAN JOURNAL OF HEART FAILURE
- Safety and Efficacy of Eplerenone in Patients at High Risk for Hyperkalemia and/or Worsening Renal Function
- (2013) Romain Eschalier et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- PF-03882845, a non-steroidal mineralocorticoid receptor antagonist, prevents renal injury with reduced risk of hyperkalemia in an animal model of nephropathy
- (2013) Stephen Orena et al. Frontiers in Pharmacology
- Additional use of an aldosterone antagonist in patients with mild to moderate chronic heart failure: a systematic review and meta-analysis
- (2012) Li-jun Hu et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012
- (2012) et al. EUROPEAN JOURNAL OF HEART FAILURE
- Rationale and design of ARTS: a randomized, double-blind study of BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease
- (2012) Bertram Pitt et al. EUROPEAN JOURNAL OF HEART FAILURE
- Antihypertensive and Cardiorenal Protective Effects of SM-368229, a Novel Mineralocorticoid Receptor Antagonist, in Aldosterone/Salt-Treated Rats
- (2012) Tetsuro Nariai et al. PHARMACOLOGY
- Mechanisms of ligand specificity of the mineralocorticoid receptor
- (2011) Peter J Fuller et al. JOURNAL OF ENDOCRINOLOGY
- A double-blind, randomized study comparing the antihypertensive effect of eplerenone and spironolactone in patients with hypertension and evidence of primary aldosteronism
- (2011) Hari K Parthasarathy et al. JOURNAL OF HYPERTENSION
- SM-368229, a Novel Selective and Potent Non-steroidal Mineralocorticoid Receptor Antagonist With Strong Urinary Na+ Excretion Activity
- (2011) Tetsuro Nariai et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- The use of plasma aldosterone and urinary sodium to potassium ratio as translatable quantitative biomarkers of mineralocorticoid receptor antagonism
- (2011) Rena J Eudy et al. Journal of Translational Medicine
- Aldosterone, mineralocorticoid receptor, and heart failure
- (2011) Smail Messaoudi et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Molecular pharmacology of the mineralocorticoid receptor: Prospects for novel therapeutics
- (2011) Peter Kolkhof et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Mineralocorticoid receptor-mediated DNA damage in kidneys of DOCA-salt hypertensive rats
- (2010) Nicole Schupp et al. FASEB JOURNAL
- A New Mode of Mineralocorticoid Receptor Antagonism by a Potent and Selective Nonsteroidal Molecule
- (2010) Jérôme Fagart et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Discovery of (3S,3aR)-2-(3-Chloro-4-cyanophenyl)-3-cyclopentyl-3,3a,4,5-tetrahydro-2H-benzo[g]indazole-7-carboxylic Acid (PF-3882845), an Orally Efficacious Mineralocorticoid Receptor (MR) Antagonist for Hypertension and Nephropathy
- (2010) Marvin J. Meyers et al. JOURNAL OF MEDICINAL CHEMISTRY
- Stereochemical Requirements for the Mineralocorticoid Receptor Antagonist Activity of Dihydropyridines
- (2010) Graciela B. Arhancet et al. JOURNAL OF MEDICINAL CHEMISTRY
- Aldosterone antagonists are underused by clinicians
- (2010) Jane-Lise Samuel et al. Nature Reviews Cardiology
- Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms
- (2010) Faiez Zannad et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Frequency of Hyperkalemia and Its Significance in Chronic Kidney Disease
- (2009) Lisa M. Einhorn et al. ARCHIVES OF INTERNAL MEDICINE
- Anti-remodelling effect of canrenone in patients with mild chronic heart failure (AREA IN-CHF study): final results
- (2009) Alessandro Boccanelli et al. EUROPEAN JOURNAL OF HEART FAILURE
- Glucocorticoids Activate Cardiac Mineralocorticoid Receptors During Experimental Myocardial Infarction
- (2009) Anastasia S. Mihailidou et al. HYPERTENSION
- Reconsidering the Roles of the Mineralocorticoid Receptor
- (2009) John W. Funder HYPERTENSION
- The mineralocorticoid receptor and its coregulators
- (2009) Jun Yang et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Aldosterone causes DNA damage in vitro and in kidneys of DOCA/salt rats, mediated by the mineralocorticoid receptor
- (2009) Nicole Schupp et al. TOXICOLOGY LETTERS
- Serum Potassium and Clinical Outcomes in the Eplerenone Post–Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS)
- (2008) Bertram Pitt et al. CIRCULATION
- A Number of Marketed Dihydropyridine Calcium Channel Blockers Have Mineralocorticoid Receptor Antagonist Activity
- (2008) Jessica D. Dietz et al. HYPERTENSION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started